Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

CI Canadian Convertible Bond ETF Common (CXF) Competitors

CI Canadian Convertible Bond ETF Common logo
C$10.51 +0.02 (+0.19%)
As of 03:47 PM Eastern

CXF vs. GPH, AIM, CRDL, IPA, and APM

Should you buy CI Canadian Convertible Bond ETF Common stock or one of its competitors? MarketBeat compares CI Canadian Convertible Bond ETF Common with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CI Canadian Convertible Bond ETF Common include Graphite One (GPH), Aimia (AIM), Cardiol Therapeutics (CRDL), ImmunoPrecise Antibodies (IPA), and Andean Precious Metals (APM). These companies are all part of the "pharmaceutical products" industry.

How does CI Canadian Convertible Bond ETF Common compare to Graphite One?

Graphite One (CVE:GPH) and CI Canadian Convertible Bond ETF Common (TSE:CXF) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Graphite One's return on equity.

Company Net Margins Return on Equity Return on Assets
Graphite OneN/A -14.07% -6.61%
CI Canadian Convertible Bond ETF Common N/A N/A N/A

0.1% of Graphite One shares are owned by institutional investors. 28.8% of Graphite One shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Graphite One currently has a consensus price target of C$2.85, indicating a potential upside of 124.41%. Given Graphite One's stronger consensus rating and higher possible upside, equities analysts clearly believe Graphite One is more favorable than CI Canadian Convertible Bond ETF Common.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Graphite One
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
CI Canadian Convertible Bond ETF Common
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Graphite One's average media sentiment score of 0.00 equaled CI Canadian Convertible Bond ETF Common'saverage media sentiment score.

Company Overall Sentiment
Graphite One Neutral
CI Canadian Convertible Bond ETF Common Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Graphite OneN/AN/A-C$4.90M-C$0.07N/A
CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A

Graphite One has a beta of 1.323881, meaning that its stock price is 32% more volatile than the broader market. Comparatively, CI Canadian Convertible Bond ETF Common has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market.

Summary

Graphite One beats CI Canadian Convertible Bond ETF Common on 6 of the 8 factors compared between the two stocks.

How does CI Canadian Convertible Bond ETF Common compare to Aimia?

CI Canadian Convertible Bond ETF Common (TSE:CXF) and Aimia (TSE:AIM) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation.

CI Canadian Convertible Bond ETF Common has a net margin of 0.00% compared to Aimia's net margin of -3.17%. CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Aimia's return on equity.

Company Net Margins Return on Equity Return on Assets
CI Canadian Convertible Bond ETF CommonN/A N/A N/A
Aimia -3.17%-3.98%-4.93%

Aimia has a consensus target price of C$3.00, indicating a potential upside of 9.89%. Given Aimia's stronger consensus rating and higher possible upside, analysts plainly believe Aimia is more favorable than CI Canadian Convertible Bond ETF Common.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CI Canadian Convertible Bond ETF Common
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aimia
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

CI Canadian Convertible Bond ETF Common has a beta of 0.75, suggesting that its share price is 25% less volatile than the broader market. Comparatively, Aimia has a beta of 0.027707, suggesting that its share price is 97% less volatile than the broader market.

CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than Aimia.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A
AimiaC$476.60M0.51-C$78.81M-C$0.15N/A

In the previous week, Aimia had 4 more articles in the media than CI Canadian Convertible Bond ETF Common. MarketBeat recorded 4 mentions for Aimia and 0 mentions for CI Canadian Convertible Bond ETF Common. Aimia's average media sentiment score of 1.22 beat CI Canadian Convertible Bond ETF Common's score of 0.00 indicating that Aimia is being referred to more favorably in the news media.

Company Overall Sentiment
CI Canadian Convertible Bond ETF Common Neutral
Aimia Positive

6.8% of Aimia shares are owned by institutional investors. 3.3% of Aimia shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Aimia beats CI Canadian Convertible Bond ETF Common on 7 of the 11 factors compared between the two stocks.

How does CI Canadian Convertible Bond ETF Common compare to Cardiol Therapeutics?

CI Canadian Convertible Bond ETF Common (TSE:CXF) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

In the previous week, CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
CI Canadian Convertible Bond ETF Common Neutral
Cardiol Therapeutics Neutral

CI Canadian Convertible Bond ETF Common has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, Cardiol Therapeutics has a beta of 0.240689, suggesting that its stock price is 76% less volatile than the broader market.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
CI Canadian Convertible Bond ETF CommonN/A N/A N/A
Cardiol Therapeutics N/A -229.16%-54.15%

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

CI Canadian Convertible Bond ETF Common beats Cardiol Therapeutics on 3 of the 5 factors compared between the two stocks.

How does CI Canadian Convertible Bond ETF Common compare to ImmunoPrecise Antibodies?

CI Canadian Convertible Bond ETF Common (TSE:CXF) and ImmunoPrecise Antibodies (CVE:IPA) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

In the previous week, CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.00 equaled ImmunoPrecise Antibodies'average media sentiment score.

Company Overall Sentiment
CI Canadian Convertible Bond ETF Common Neutral
ImmunoPrecise Antibodies Neutral

Company Net Margins Return on Equity Return on Assets
CI Canadian Convertible Bond ETF CommonN/A N/A N/A
ImmunoPrecise Antibodies N/A N/A N/A

CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than ImmunoPrecise Antibodies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A
ImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89N/A

Summary

ImmunoPrecise Antibodies beats CI Canadian Convertible Bond ETF Common on 1 of the 1 factors compared between the two stocks.

How does CI Canadian Convertible Bond ETF Common compare to Andean Precious Metals?

CI Canadian Convertible Bond ETF Common (TSE:CXF) and Andean Precious Metals (CVE:APM) are both small-cap manufacturing companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

CI Canadian Convertible Bond ETF Common has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, Andean Precious Metals has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

In the previous week, Andean Precious Metals had 1 more articles in the media than CI Canadian Convertible Bond ETF Common. MarketBeat recorded 1 mentions for Andean Precious Metals and 0 mentions for CI Canadian Convertible Bond ETF Common. Andean Precious Metals' average media sentiment score of 1.48 beat CI Canadian Convertible Bond ETF Common's score of 0.00 indicating that Andean Precious Metals is being referred to more favorably in the news media.

Company Overall Sentiment
CI Canadian Convertible Bond ETF Common Neutral
Andean Precious Metals Positive

13.2% of Andean Precious Metals shares are owned by institutional investors. 69.4% of Andean Precious Metals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Andean Precious Metals has a net margin of 16.17% compared to CI Canadian Convertible Bond ETF Common's net margin of 0.00%. Andean Precious Metals' return on equity of 20.32% beat CI Canadian Convertible Bond ETF Common's return on equity.

Company Net Margins Return on Equity Return on Assets
CI Canadian Convertible Bond ETF CommonN/A N/A N/A
Andean Precious Metals 16.17%20.32%4.13%

Andean Precious Metals has higher revenue and earnings than CI Canadian Convertible Bond ETF Common.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A
Andean Precious MetalsC$154.78M0.88C$37.41MC$0.512.55

Summary

Andean Precious Metals beats CI Canadian Convertible Bond ETF Common on 9 of the 9 factors compared between the two stocks.

Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically

Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CXF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CXF vs. The Competition

MetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE Exchange
Market CapC$60.40MC$927.43MC$4.26BC$12.16B
Dividend Yield4.84%4.84%5.93%6.20%
P/E RatioN/A0.9818.4037.64
Price / SalesN/A119.63180.5511.68
Price / CashN/A20.0755.6882.29
Price / BookN/A7.5934.854.50
Net IncomeN/A-C$3.64MC$112.32MC$299.09M
7 Day PerformanceN/A1.93%2.55%1.38%
1 Month Performance0.10%76.78%3.54%1.46%
1 Year Performance4.89%126.62%15.79%55.45%

CI Canadian Convertible Bond ETF Common Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CXF
CI Canadian Convertible Bond ETF Common
N/AC$10.51
+0.2%
N/A+4.7%C$60.40MN/AN/A90
GPH
Graphite One
1.3361 of 5 stars
C$1.16
+2.7%
C$2.85
+145.7%
+48.7%C$241.78MN/AN/A20
AIM
Aimia
2.3791 of 5 stars
C$2.71
+0.7%
C$3.00
+10.7%
-2.9%C$240.62MC$483.40M7.1320
CRDL
Cardiol Therapeutics
N/AC$1.74
-3.9%
N/A+19.7%C$200.57MN/AN/A20
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47MN/A80

Related Companies and Tools


This page (TSE:CXF) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners